UPClytics
EnglishDeutsch
Sign inSign up
View all cases

UPC CFI 41/2025

Jan 22, 2025·EP1830843: INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Case details
Status
Case Closed
Action
Provisional measures
Category
Provisional Measures
Parties
Claimants
Reps: Joana Piriquito Santos
Respondents
Reps: Patricia Paias
Division
Lisbon LD
Judges
Technology
Organic Chemistry
Language
English
Documents
Document titleDatePublic
Outcome of the Order2025-05-26Not public
Declaration2025-05-26Public
Outcome of the Order2025-05-21Not public
Template-order2025-05-16Public
Declaration2025-05-16Public
Measures_DecisionOutcome_Notification.pdf2025-05-16Not public
Final order2025-05-08Public
Receipt2025-04-22Not public
Request to the Registrar for the recording of the oral hearing to be made available2025-04-22Not public
record2025-04-16Not public
record2025-04-16Not public
Receipt2025-04-16Not public
Final order - CMS purposes2025-04-16Public
Template-Order2025-04-16Not public
Request recording oral hearing2025-04-15Not public
Response under Order April 2, 20252025-04-10Not public
Response under APP 15653.20252025-04-10Not public
Receipt2025-04-09Not public
Call for proposals under framework agreement - Part 32025-04-08Not public
Generic Procedural Appplication2025-04-08Not public
Decision and Final Report under Framework Agreement - Part 32025-04-08Not public
Decision and Final Report under Framework Agreement - Part 12025-04-08Not public
Decision and Final Report under Framework Agreement - Part 22025-04-08Not public
Decision and Final Report under Framework Agreement - Part 52025-04-08Not public
Decision and Final Report under Framework Agreement - Part 42025-04-08Not public
Call for proposals under framework agreement - Part 42025-04-08Not public
Call for proposals under framework agreement - Part 22025-04-08Not public
Call for Proposals under Framework Agreement (Reference: 1283/2025) - Part 12025-04-08Not public
Receipt2025-04-07Not public
Receipt2025-04-07Not public
Exhibit 22025-04-07Not public
Response under Order App 15653.2025 of April 2, 20252025-04-07Not public
Exhibit 1 - Permanent Certificate2025-04-07Not public
Response under Order of April 2, 20252025-04-07Not public
Exhibit 12025-04-07Not public
Applicant's note on award of costs2025-04-07Not public
Exhibit 272025-04-07Not public
Exhibit 262025-04-07Not public
BI reply to Zentiva evidence submission2025-04-04Not public
BI reply to Zentiva evidence submission2025-04-04Not public
BI reply to Zentiva evidence submission2025-04-04Not public
BI reply to Zentiva evidence submission2025-04-04Not public
BI reply to Zentiva evidence submission2025-04-04Not public
BI reply to Zentiva evidence submission2025-04-04Not public
Order2025-04-02Not public
Receipt2025-04-02Not public
Order2025-04-02Not public
Order2025-03-31Not public
Exhibit 25 - Defence SPMS2025-03-31Not public
Exhibit 20 - Declaration Vanessa Jacinto2025-03-31Not public
Application - written2025-03-31Not public
Exhibit 21 - Declaration Manuela Kreuder2025-03-31Not public
Exhibit 22 - Zentiva atos societarios2025-03-31Not public
Exhibit 25 - Defence SPMS2025-03-31Not public
Exhibit 24 - Defence Zentiva2025-03-31Not public
Exhibit 24 - Defence Zentiva2025-03-31Not public
Exhibit 23 - Article Prof. Marco Caldeira2025-03-31Not public
Exhibit 23 - Article Prof. Marco Caldeira2025-03-31Not public
Exhibit 22 - Zentiva atos societarios2025-03-31Not public
Receipt2025-03-31Not public
Order2025-03-31Not public
Application for Written Witnesses Statements2025-03-31Not public
Written Statement - Ana Lopes2025-03-31Not public
Written Statement - Ana Teixeira2025-03-31Not public
Receipt2025-03-31Not public
Generic Procedural Appplication2025-03-28Not public
Exhibit 1 - TPI Decision2025-03-28Not public
Receipt2025-03-24Not public
Exhibit 4 - Order 1771-B_20162025-03-21Not public
Exhibit 2 - Order 55_20132025-03-21Not public
Rejoinder2025-03-21Not public
Exhibit 1 - Proof of Judicial Certificate2025-03-21Not public
Exhibit 3 - Decree-law 19_20102025-03-21Not public
Receipt2025-03-13Not public
Reply to the Objection2025-03-12Not public
EXHIBIT 192025-03-12Not public
EXHIBIT 182025-03-12Not public
EXHIBIT 172025-03-12Not public
Acknowledgement-of-lodging2025-03-07Not public
Request remit to Objection filed 03.03.252025-03-07Not public
Summon-Oral-Hearing2025-03-06Not public
Order2025-03-06Public
Oral hearing2025-03-03Not public
Order 209.1(b) RoP2025-03-03Public
Oral hearing2025-03-03Not public
Template-Order2025-03-03Not public
Receipt2025-03-03Not public
Exhibit 2 - Case 57/25.1YHLSB (i)2025-03-03Not public
Exhibit 5 - Clarification Boehringer Ingelheim Portugal 30.01.20252025-03-03Not public
Exhibit 4 - Specifications Framework Agreement no 491/2023 - part 42025-03-03Not public
Exhibit 3 - Framework Agreement Nintedanib - part 22025-03-03Not public
Exhibit 1 - Certificate SPC 6792025-03-03Not public
Exhibit 4 - Specifications Framework Agreement no 491/2023 - part 12025-03-03Not public
Exhibit 4 Specifications Framework Agreement no 491/2023 - part 32025-03-03Not public
Exhibit 3 - Framework Agreement Nintedanib - part 32025-03-03Not public
Exhibit 3 - Framework Agreement Nintedanib - part 12025-03-03Not public
Exhibit 1 - Certificate SPC 6792025-03-03Not public
Objection provisional measures application2025-03-03Not public
Exhibit 4 Specifications Framework Agreement no 491/2023 - part 22025-03-03Not public
Exhibit 2 - Case 57/25.1YHLSB - part 22025-03-03Not public
Exhibit 2 - Case 57/25.1YHLSB - part 32025-03-03Not public
Acknowledgement of access to case2025-02-24Not public
Notification Of Service2025-02-10Not public
receipt confirmation2025-02-10Not public
Letter-for-Service2025-01-30Not public
Preliminary Order - R.2092025-01-29Not public
Preliminary Order - R.2092025-01-29Not public
Template-Order2025-01-29Not public
Preliminary Order - R.2092025-01-29Not public
Panel-Appointment2025-01-29Not public
Application-For-Measures-Receipt2025-01-23Not public
Formal-checks_Notification-of-positive-outcome2025-01-23Not public
Exhibit 8 - Decision of China National Intellectual Property Administration2025-01-23Not public
Exhibit 1- Boehringer Ingelheim Pharma GmbH & Co. KG authorized Boehringer Ingelheim International GmbH to file to proc2025-01-23Not public
Exhibit 14 - EP 1 830 843 B1opt-out and withdrawal of the opt-out2025-01-23Not public
Application for provisional measures2025-01-23Not public
Exhibit 11 - Zentiva: authorised and registered wholesale distributor of medicines2025-01-23Not public
Exhibit 15 - IQVIA DATA2025-01-23Not public
Exhibit 6 - EP 1 830 843 B1 decision of the OD of the EPO2025-01-23Not public
Exhibit 3 - EP 1 830 843 B12025-01-23Not public
Exhibit 12- Zentiva Generics SmPC and PL (PT and EN)2025-01-23Not public
Exhibit 2 - Ofev Summary of Product Characteristics and Package Leaflet2025-01-23Not public
Exhibit 4 - EP 1 830 843 B1 EPO registrar and national registrars2025-01-23Not public
Exhibit 9 - Zentiva Generics MAs: INFOMED extract (PT and ENG)2025-01-23Not public
Exhibit 16 - Written statement from Mariana Nascimento2025-01-23Not public
Response to the request for amendments2025-01-23Not public
Exhibit 7 - Decision of the Federal Court of Canada2025-01-23Not public
Proof of payment of court fees2025-01-23Not public
Exhibit 10 - Zentiva Generics: DCP procedure2025-01-23Not public
Exhibit 5 - Boehringer Ingelheim Pharma GmbH & Co. KG authorization2025-01-23Not public
Exhibit 13 - Notice no. 0689/2024 (PT and EN)2025-01-23Not public
Formal-checks_Request-for-correction2025-01-22Not public
Application-For-Measures-Acknowledgement2025-01-21Not public
Exhibit 6 - EP 1 830 843 B1 decision of the OD of the EPO2025-01-21Not public
Exhibit 14 - EP 1 830 843 B1opt-out and withdrawal of the opt-out2025-01-21Not public
Exhibit 10 - Zentiva Generics: DCP procedure2025-01-21Not public
Exhibit 3 - EP 1 830 843 B12025-01-21Not public
Exhibit 4 - EP 1 830 843 B1 EPO registrar and national registrars2025-01-21Not public
Exhibit 5 - Boehringer Ingelheim Pharma GmbH & Co. KG authorization2025-01-21Not public
Application for provisional measures2025-01-21Not public
Exhibit 12- Zentiva Generics SmPC and PL (PT and EN)2025-01-21Not public
Exhibit 15 - IQVIA DATA2025-01-21Not public
Exhibit 1- Boehringer Ingelheim Pharma GmbH & Co. KG authorized Boehringer Ingelheim International GmbH to file to proc2025-01-21Not public
Exhibit 16 - Written statement from Mariana Nascimento2025-01-21Not public
Exhibit 2 - Ofev Summary of Product Characteristics and Package Leaflet2025-01-21Not public
Proof of payment of court fees2025-01-21Not public
Exhibit 9 - Zentiva Generics MAs: INFOMED extract (PT and ENG)2025-01-21Not public
Exhibit 11 - Zentiva: authorised and registered wholesale distributor of medicines2025-01-21Not public
Exhibit 8 - Decision of China National Intellectual Property Administration2025-01-21Not public
Exhibit 13 - Notice no. 0689/2024 (PT and EN)2025-01-21Not public
Exhibit 7 - Decision of the Federal Court of Canada2025-01-21Not public